Shanghai MedValley is located in the heart of Jiading New City. [Photo/jiading.gov.cn]
Jiading district's biopharmaceutical industry is experiencing significant growth, with a total output of 24.81 billion yuan ($3.42 billion) in the first three quarters of 2024, a year-on-year increase of 1.3 percent. This positions Jiading fourth in the city for output scale and third for growth rate.
Recent investments highlight Jiading's commitment to the industry. On Oct 16, 24 new biopharmaceutical projects were signed with a total investment exceeding 2 billion yuan. Jin Huajun, founder of Shanghai-based biotechnology company Juncell, praised the comprehensive support from Jiading's government, which has accelerated the landing of their TIL industrialization base project.
Over the past year, Jiading has focused on industrial aggregation, innovation-driven development, park development, and capital empowerment to enhance the district's biopharmaceutical capabilities.
In 2023, Jiading released policies offering up to 50 million yuan in support for biopharmaceutical companies. Liang Dongke of Intl-Medical noted that these policies boost their confidence and focus on innovation. Intl-Medical added 66 patents and 19 medical device product registrations this year, with products sold in over 70 countries and a strong domestic presence in over 2,660 hospitals.
The district is actively creating a biopharmaceutical industry pattern characterized by a logical layout, clear positioning, differentiated development, and significant benefits.
Key areas like United Imaging Town and Shanghai MedValley are developing clusters for high-end medical equipment and innovative medical devices.
Focusing on high precision and "bottleneck" technologies, the district is striving to become a leading innovation zone and a new growth pole for Shanghai's world-class biopharmaceutical industry cluster.
United Imaging Town fosters the growth of high-end medical equipment clusters and attracts related upstream and downstream industrial projects. [Photo/jiading.gov.cn]